Fierce Biotech December 21, 2022
A closed-loop system—commonly referred to as an artificial pancreas—could one day manage a user’s diabetes around the clock, eliminating the need for fingersticks, regular check-ins with a glucose monitor or manual adjustments to insulin doses based on meals or activity.
During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha pinpointed the emerging concept of “technology ecosystems,” specifically highlighting those designed to simplify diabetes management.
Those ecosystems, he explained, comprise “sensors and delivery devices and algorithms and wearables that are all coming together to really put diabetes in the background for patients.”
Today's Sponsors
Today's Sponsor